January 22, 2018
Cardiovascular disease frequently coexists with chronic obstructive pulmonary disease and contributes to mortality. A research team led by Fisk investigated 458 patients with a diagnosis of […]
January 5, 2018
Patients with resistant hypertension have heightened blood pressure despite using antihypertensive drugs. Venioles’s team investigated the effects of different additional therapies, renal denervation or antihypertensive, in participants with resistant hypertension on existing diuretic treatment. Central pulse pressure was significantly decreased within the antihypertensive group indicating that including additional targeted hypertensive therapy in combination with existing treatment could help mitigate target organ damage in resistant hypertensive.
December 6, 2017
Roneé Harvey at the University of Wisconsin–Madison investigated aortic hemodynamics in postmenopausal women after stopping hormone therapy. Their study, a randomized, double-blind, placebo-controlled clinical trial, found […]
September 17, 2017
Luana de Rezende Mikael and her team explored the connection between vascular aging and arterial stiffness. Their manuscript covered the physiopathogenesis of vascular aging, methods for […]
May 25, 2017
A research group led by Julio Chirinos assessed effects of organic and inorganic nitrate on patients with heart failure with preserved ejection fraction (HFpEF). The team […]
February 20, 2017
Darragh O’Neill and a team from University College London investigated 25 years of prospective data to assess the connection between alcohol consumption and alterations in arterial […]
February 3, 2017
A team led by Peter Wohlfahrt from the Mayo Clinic conducted the first longitudinal trial in heart failure with reduced ejection fraction (HFrEF) patients where changes […]
January 10, 2017
A research team at University of Oslo led Tove Lekva investigated the association between gestational diabetes mellitus (GDM), cardiovascular risk, and plasma adiponectin, leptin, and the […]
March 22, 2016
Current therapeutic strategies targeting insulin resistance have not shown evidence of reducing cardiovascular risk in diabetes patients, prompting the search for alternative therapies. Blaslov and Duvnjak […]